2015
DOI: 10.1007/s11154-016-9326-7
|View full text |Cite
|
Sign up to set email alerts
|

Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)

Abstract: Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of unclear etiopathogenesis that is likely to involve genetic and environmental components synergistically contributing to its phenotypic expression. Endocrine disrupting chemicals (EDCs) and in particular Bisphenol A (BPA) represent a group of widespread pollutants intensively investigated as possible environmental contributors to PCOS pathogenesis. Substantial evidence from in vitro and animal studies incriminates endocrine disruptors in the induct… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
65
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
6
2
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 120 publications
(71 citation statements)
references
References 73 publications
0
65
0
Order By: Relevance
“…However, it is believed that the most likely vulnerable period of exposure is in utero and the first few years of life (26). The reasoning proposes that animal studies of exogenous androgen exposure and human evidence of in utero growth restriction with subsequent catch-up growth, leading to the subsequent development of features of PCOS and the metabolic syndrome, suggest that a period of vulnerability exists at this time to individuals who may have a genetic predisposition to PCOS (26,246). Indeed, with the use of both high-and low-dose exposures to BPA in early postnatal life, a rodent model of PCOS has been developed (103).…”
Section: Influences On Follicular Development and Ovulationmentioning
confidence: 99%
“…However, it is believed that the most likely vulnerable period of exposure is in utero and the first few years of life (26). The reasoning proposes that animal studies of exogenous androgen exposure and human evidence of in utero growth restriction with subsequent catch-up growth, leading to the subsequent development of features of PCOS and the metabolic syndrome, suggest that a period of vulnerability exists at this time to individuals who may have a genetic predisposition to PCOS (26,246). Indeed, with the use of both high-and low-dose exposures to BPA in early postnatal life, a rodent model of PCOS has been developed (103).…”
Section: Influences On Follicular Development and Ovulationmentioning
confidence: 99%
“…Women with PCOS or T2DM are reported to have ovarian dysfunction, low implantation rates, slow development, and high miscarriage rates [1,[17][18][19]. However, the underlying mechanism of this phenomenon is still unknown.…”
Section: Animal Model and Tissue Collectionmentioning
confidence: 99%
“…Clinical data demonstrate increased levels of BPA in patients with PCOS [25], and the levels can reach those in males [26]. PCOS induced by BPA exposure is also associated with hyperandrogenism and hyperinsulinism.…”
Section: Introductionmentioning
confidence: 98%